Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I Study of Gemcitabine (Gemzar) and UFT [tegafur/uracil],/Leucovorin [folinic acid].

Trial Profile

Phase I Study of Gemcitabine (Gemzar) and UFT [tegafur/uracil],/Leucovorin [folinic acid].

Phase of Trial: Phase I

Latest Information Update: 05 Apr 2013

At a glance

  • Drugs Folinic acid (Primary) ; Gemcitabine (Primary) ; Tegafur/uracil (Primary)
  • Indications Cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 18 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 18 Apr 2010 Actual end date (Aug 2007) added as reported by ClinicalTrials.gov.
    • 29 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top